221 related articles for article (PubMed ID: 11135781)
1. Pulmonary hypertension.
Gaine S
JAMA; 2000 Dec; 284(24):3160-8. PubMed ID: 11135781
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic management of primary pulmonary hypertension].
Chaouat A; Weitzenblum E
Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension: new perspectives.
Nauser TD; Stites SW
Congest Heart Fail; 2003; 9(3):155-62. PubMed ID: 12826774
[TBL] [Abstract][Full Text] [Related]
4. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
5. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing and treating primary pulmonary hypertension.
Frazier SK
Nurse Pract; 1999 Sep; 24(9):18, 21-2, 25-6 passim; quiz 42-3. PubMed ID: 10507069
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hypertension: the issues of diagnosis and treatment].
Sakalauskas R; Barkauskiene D; Vebriene J; Sadauskas S
Medicina (Kaunas); 2004; 40(10):1019-25. PubMed ID: 15516828
[TBL] [Abstract][Full Text] [Related]
8. Current management of primary pulmonary hypertension.
Klings ES; Farber HW
Drugs; 2001; 61(13):1945-56. PubMed ID: 11708765
[TBL] [Abstract][Full Text] [Related]
9. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Badesch DB; Tapson VF; McGoon MD; Brundage BH; Rubin LJ; Wigley FM; Rich S; Barst RJ; Barrett PS; Kral KM; Jöbsis MM; Loyd JE; Murali S; Frost A; Girgis R; Bourge RC; Ralph DD; Elliott CG; Hill NS; Langleben D; Schilz RJ; McLaughlin VV; Robbins IM; Groves BM; Shapiro S; Medsger TA
Ann Intern Med; 2000 Mar; 132(6):425-34. PubMed ID: 10733441
[TBL] [Abstract][Full Text] [Related]
10. Current medical treatment of pulmonary arterial hypertension.
Sulica R; Poon M
Mt Sinai J Med; 2004 Mar; 71(2):103-14. PubMed ID: 15029402
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodium.
Castro PF; Bourge RC; McGiffin DC; Benza RL; Fan P; Pinkard NB; McGoon MD
Chest; 1998 Jul; 114(1):334-6. PubMed ID: 9674493
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
13. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.
Langleben D; Barst RJ; Badesch D; Groves BM; Tapson VF; Murali S; Bourge RC; Ettinger N; Shalit E; Clayton LM; Jöbsis MM; Blackburn SD; Crow JW; Stewart DJ; Long W
Circulation; 1999 Jun; 99(25):3266-71. PubMed ID: 10385501
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary arterial hypertension].
Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).
Humbert M; Sanchez O; Fartoukh M; Jagot JL; Sitbon O; Simonneau G
Chest; 1998 Jul; 114(1 Suppl):80S-82S. PubMed ID: 9676646
[No Abstract] [Full Text] [Related]
18. Recognition and management of pulmonary hypertension.
Wanstall JC; Jeffery TK
Drugs; 1998 Dec; 56(6):989-1007. PubMed ID: 9878988
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension: classification and therapy with a focus on prostaglandin analogs.
Papierniak ES; Lowenthal DT; Mubarak K
Am J Ther; 2012 Jul; 19(4):300-14. PubMed ID: 21642835
[TBL] [Abstract][Full Text] [Related]
20. Primary pulmonary hypertension. World Health Organization.
Fauzi AR
Med J Malaysia; 2000 Dec; 55(4):529-37; quiz 538. PubMed ID: 11221172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
